Wednesday, September 19, 2018
Company News: Page (1) of 1 - 04/09/18 Email this story to a friend. email article Print this page (Article printing at page facebook
USD 9.49 billion Growth and Research of Radiopharmaceuticals Market Report, Outlook, Share and Analysis With Top Vendors Key Players Like Cardinal Health, MallinckrodtPlc. and GE Healthcare by 2024

(April 09, 2018)

""Global Radiopharmaceuticals Market" is expected to reach USD 9.49 billion by 2024 from USD 4.87 billion in 2016, at a CAGR of 8.7% in the forecast period 2017 to 2024."
Data Bridge Market Research report provides an extensive analysis of current and future market status of the “Global Radiopharmaceuticals Market” First time buyer? check offers and avail 10% Discount on Direct Purchase this report mail us at [email protected] Or call on number +1-888-387-2818

According to Data Bridge Market Research new report Radiopharmaceuticals Market gives rising open doors in the market and the future effect of significant drivers and difficulties and, bolster leaders in settling on practical business choices. Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity.

"Global Radiopharmaceuticals Market" is expected to reach USD 9.49 billion by 2024 from USD 4.87 billion in 2016, at a CAGR of 8.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Click Here for Free Sample Report Visit @

Recent Developments: Radiopharmaceuticals Market

Recent trends in the radiopharmaceuticals market such as growing disease which targeted cancer therapy, increasing awareness, expanding applications of molecular imaging, technological advancement, increasing trend of radio-labelled peptides and monoclonal antibodies for the diagnosis and treatment of cancer tumors and increasing use of SPECT & PET scans is expected to drive the market in the forecast period 2017 to 2024.

Radiopharmaceuticals are mostly used for treatment of cancer, bone pain, and thyroid cancer. In the U.S. cancer is second fatal disease whereas in the UK it is the leading cause of death. In most of the third world countries cancer appears much lower. Cancer is the second leading cause of death globally and was responsible for 8.8 million deaths in 2015. Globally, nearly 1 in 6 deaths is due to cancer. In 2016, an estimated 1.6 million new cases of cancer was diagnosed in the United States and 0.5 million people died from the disease.

On the other hand, shorter half-life of radiopharmaceuticals, stringent regulatory guidelines and competition from conventional diagnostic procedures are some of the factors which may hinder the growth of radiopharmaceuticals market.

Market Segmentation:

The global market is segmented based on type, procedural volumes, application, sources, end-user, and geography.

On the basis of type, the global radiopharmaceuticals market is sub-segmented into

  • Diagnostic
  • Therapeutic radiopharmaceuticals.

In 2017, diagnostic radiopharmaceuticals segment dominate the market and is expected to grow at the highest in the forecast period. This is due to the production of MO-99 in the U.S., FDA approvals of radiopharmaceuticals, initiatives of International Atomic Energy Agency (IAEA), new irradiation facility in Germany, installation of PET scanners in India, andgovernment investments in Rest of Asia-Pacific.

On the basis of procedural volumes, the global radiopharmaceuticals market is sub-segmented into

  1. Diagnostic procedure
  • single-photon emission computed tomography (SPECT) radiopharmaceuticals
  • positron emission tomography (PET) radiopharmaceuticals
  1. Therapeutic procedures
  • beta emitters
  • alpha emitters
  • brachy therapy

On the basis of application, the global radiopharmaceuticals market is sub-segmented into

  1. diagnostic application
  • single-photon emission computed tomography (SPECT) -
  • positron emission tomography (PET)- oncology, cardiology, neurology and others
  1. therapeutic application
  • thyroid,
  • bone metastasis,
  • lymphoma,
  • endocrine tumours
  • others

On the basis of sources, the global radiopharmaceuticals market is sub-segmented into

  • nuclear reactors
  • cyclotrons

On the basis of end user, the global radiopharmaceuticals market is sub-segmented into

  • hospitals,
  • ambulatory surgical centers,
  • diagnostic centers,
  • cancer research institutes and
  • others

 In 2017, hospital segment dominate the market with the highest market share due to accessibility of highly skilled medical practitioners in the radiology departments of hospitals.

Request for Table of Content of Full Report @

Major Players in Global Radiopharmaceuticals Market are included which give a brief analysis of following points:

  • Market Overview
  • Market Dynamics
  • Drivers, Restraints, Opportunities and Challenges
  • Market sizing and growth analysis
  • Market forecasting to 2024
  • Market Competitive Landscape
  • Product Launches and Pipeline Analysis
  • Value Chain Analysis
  • Market Mergers, Acquisitions and Agreements
  • Company Profiles


Top Challengers:


  • Cardinal Health Inc.
  • MallinckrodtPlc.
  • GE Healthcare
  • Lantheus Medical Imaging Inc.
  • Bayer AG
  • Bracco Imaging SpA
  • Eczacibasi-Monrol Nuclear Products
  • Nordion Inc.
  • Advanced Accelerator Applications S.A.
  • IBA Molecular Imaging
  • Actinium Pharmaceuticals Inc.,
  • Among others.


Read more about Report Visit @


Related Report

North America Digital Health Monitoring Market – Industry Trends and Forecast to 2024

North America Digital Health Monitoring Market By Product Type Devices (Blood Pressure Monitors, Blood Glucose Monitors, ECG, Oximeters, Peak Flow Monitors, Multi Parameter Monitors, Sleep Neap Monitors, Neurological Monitors, Others), Software (Healthcare Apps, Chronic Disease Apps, Personal Health Apps, Others), Services (Remote Monitoring, Consultancy Services, Treatment Services, Fitness and Wellness Services, Others), By Country (U.S., Canada, Mexico) –  Industry Trends and Forecast to 2024

Report Access:

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]


Media Contact

Company Name: Data Bridge Market Research Private LimitedContact Person: Sopan Gedam

Email: [email protected]
Phone: 18883872818
Address:Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India


Page: 1

Related Keywords:News & Current Affairs,Pharmaceuticals & Biotech,U.S,Website & Blog,World,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • ChenMed to Invest More Than $200 Million to Bring Affordable Concierge-Style Health Care to Philadelphia Seniors
  • Consuelo M. Alvarez, M.D., MBA, is recognized by Continental Who's Who
  • IV Infusion Pump Accessories Market is poised to register a CAGR of 4.5% by 2025 – Persistence Market Research
  • Effie Chow Qigong Healing System Available On Mediterranean Celebrity Cruise Line Says Sharon Kleyne & Rose Hong
  • The Methuselah Foundation Successfully Closes its Boutique Venture Fund, the Methuselah Fund, Focused on Companies That Can Extend the Healthy Human Lifespan

  • Sequana Medical reports positive data on use of the alfapump® in malignant ascites patients at the International Gynecologic Cancer Society
  • Cleveland Cavaliers' Kevin Love Launches The Kevin Love Fund To Promote Physical And Mental Wellness
  • BioPlus Specialty Pharmacy Announces New President: Mark Montgomery
  • Astellas Promotes Geoff Towle to Vice President of Oncology Marketing at Astellas US
  • Chardan Advises NovellusDX in Cross-Border Biotech Merger

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines